Clinical and radiographics evaluation of titanium-zirconium narrow-diameter dental implants. A multicenter randomized, controlled clinical trial.

Clinical and radiographics evaluation of titanium-zirconium narrow-diameter dental implants. A multicenter randomized, controlled clinical trial. - Roxolid

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00006167

Enrollment

Registered

2014-05-15

Start date

2010-02-17

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

K08.1

Interventions

Group 1: Test: Titanium-zirconium implants (Straumann Bone Level) with narrow diameter (3.3 mm) Group 2: Control: conventional Titanium-Implant (Straumann Bone Level) with regular diameter (4.1 mm)

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: - good oral hygiene - presence of adequate quantity and quality of native bone to achieve primary implant stability - presence of sufficient mesio-distal space for the placement of a regular diameter implant (4.1 mm)

Exclusion criteria

Exclusion criteria: - active periodontal disease - heavy smoking (> 10 cigarettes/day), pipe or cigar smoking

Design outcomes

Primary

Measure	Time frame
change of the marginal bone level after 5 years (X-ray)	—

Secondary

Measure	Time frame
- intraoperative time for the implant bed preparation - dimensions of the osseous defects after the implant placement - operator’s perception of the procedure - implant survival, complication rates, clinical soft tissue parameters after 1, 3 and 5 years	—

Countries

Switzerland, United States

Contacts

Public ContactGoran I. Benic

Zentrum für Zahnmedizin

goran.benic@zzm.uzh.ch+41 44 634 04 04

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026